PMA device
CALCIVIS Imaging System
Calcivis Limited · Caries Detection Product With Drug Or Biologic (QJX, Class III) · First FDA decision Mar 7, 2023, newest Mar 3, 2025Tooth decay and restorations
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
3
Naming "CALCIVIS"
MAUDE reports
0
Brand "CALCIVIS", since 2015
PubMed studies
4
Mentioning "CALCIVIS"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing CALCIVIS Imaging System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- CALCIVIS Imaging SystemPMA supplement
P170029-S004 · Decided Mar 3, 2025 · 90 days after receipt · Normal 180 Day Track
Device type: Caries detection product with drug or biologic (QJX) · Dentistry & Oral Surgery
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "CALCIVIS", any status and sponsor, newest update first.
Calcivis LtdNot on our public-company list
NCT02771522 · 36 participants · Start Feb 15, 2017 · Primary completion Jun 5, 2018
Device: Calcivis System · For: Dental Caries
Sites: Edinburgh, United Kingdom
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "CALCIVIS", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QJX
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "CALCIVIS"[tiab]. The summary above synthesizes these.
- Agreement of Bioluminescence Measurements and Visual Assessment in Monitoring Occlusal Surfaces of Permanent Teeth.
Jablonski-Momeni A, Jablonski B, Heinzel-Gutenbrunner M, et al. · J Clin Med · 2022
- The Calcivis story - enamel caries activity assessment from technology to practice.
Pitts NB, Longbottom C, Christie A, et al. · Br Dent J · 2021Research Support, Non-U.S. Gov't
- A Critical Review of the Validity and Reliability of Caries Detection Methods for Non-Cavitated Lesions.
Murukutla S, Ismail A · Caries Res · 2026Review
- Validity of Soprolife camera and Calcivis device in caries lesion activity assessment.
Drancourt N, Roger-Leroi V, Pereira B, et al. · Br Dent J · 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.